𝔖 Bobbio Scriptorium

✦ LIBER ✦

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)

✍ Scribed by Joachim Schofer; Michael Schlüter; Anthony H Gershlick; William Wijns; Eulogio Garcia; Erick Schampaert; Günter Breithardt

Book ID: 117284658
Publisher: The Lancet
Year: 2003
Tongue: English
Weight: 115 KB
Volume: 362
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(03)14462-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trial finds sirolimus eluting stents red

Trial finds sirolimus eluting stents reduce restenosis in people with long atherosclerotic lesions in small coronary arteries: Abstracted from: Schofer J, Schlüter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003;362(9390):1093–9

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Sirolimus-eluting stents for treatment o

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS)

✍ J Schofer; M Schlüter; A.H Gershlick 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Cost-effectiveness of sirolimus-eluting

Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: Results from the sirolimus-eluting balloon expandable stent in the treatment of patients with De Novo Native Coronary Artery Lesions (SIRIUS) trial

✍ D.J. Cohen; A. Bakhai; C. Shi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Safety and Efficacy of the 2.25-mm Sirol

Safety and Efficacy of the 2.25-mm Sirolimus-Eluting Bx Velocity Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial

✍ Jeffrey W. Moses; Eugenia Nikolsky; Roxana Mehran; Patrick A. Cambier; William B 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Rationale and design of the dual antipla

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

✍ Laura Mauri; Dean J. Kereiakes; Sharon-Lise T. Normand; Stephen D. Wiviott; Davi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB